Anemia and Kidney Disease
A team analyzed sotagliflozin's effects on hemoglobin in patients with stage 3-4 CKD and type 2 diabetes.
The TRANSNEMIA study addressed the need for guidelines specific to anemia in kidney transplant recipients.
A study examined the efficacy and safety of conversion from treatment with the long-acting ESA MPG-EPO to vadadustat.
Individualized dosing of ESAs using anemia therapy assistance software improved hemoglobin stability and ESA utilization.
Researchers examined the long-term safety of oral hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia of CKD.
Under a new agreement with Akebia, US Renal Care will be able to prescribe Vafseo to dialysis patients with anemia of CKD.
Anemia of CKD in China and its related health care costs are projected to rise, but earlier screening and treatment can help.
A recent study compared anemia diagnosis and treatment in older patients hospitalized in nephrology versus geriatric units.
How does early vs delayed treatment with long-acting ESAs affect renal and cardiovascular outcomes in patients with NDD-CKD?
Researchers used KPIs to evaluate anemia and iron status management in children on hemodialysis.
A study examined the prevalence of iron deficiency and associated factors in patients with stage 4-5 CKD.
A study examined the effect of an egg white diet in relation to anemia in patients with end-stage renal disease on dialysis.
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.